中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
26期
32-33
,共2页
依那普利%氢氯噻嗪%高血压%临床疗效%分析
依那普利%氫氯噻嗪%高血壓%臨床療效%分析
의나보리%경록새진%고혈압%림상료효%분석
Enalapril%Hydrochlorothiazide%Hypertension%Clinical efficacy%Analysis
目的:探讨依那普利联合氢氯噻嗪治疗高血压的临床疗效。方法78例高血压患者,随机分为治疗组和对照组各39例,分别采用依那普利单药治疗和依那普利联合氢氯噻嗪治疗。结果治疗组的疗效(94.87%)大于对照组(87.18%),两组差异具有统计学意义(P<0.05);治疗组的不良反应率(5.13%)小于对照组(12.82%),两组差异具有统计学意义(P<0.05)。结论依那普利联合氢氯噻嗪治疗高血压的临床疗效显著且不良反应率低,适合原发性高血压的治疗,值得临床推广。
目的:探討依那普利聯閤氫氯噻嗪治療高血壓的臨床療效。方法78例高血壓患者,隨機分為治療組和對照組各39例,分彆採用依那普利單藥治療和依那普利聯閤氫氯噻嗪治療。結果治療組的療效(94.87%)大于對照組(87.18%),兩組差異具有統計學意義(P<0.05);治療組的不良反應率(5.13%)小于對照組(12.82%),兩組差異具有統計學意義(P<0.05)。結論依那普利聯閤氫氯噻嗪治療高血壓的臨床療效顯著且不良反應率低,適閤原髮性高血壓的治療,值得臨床推廣。
목적:탐토의나보리연합경록새진치료고혈압적림상료효。방법78례고혈압환자,수궤분위치료조화대조조각39례,분별채용의나보리단약치료화의나보리연합경록새진치료。결과치료조적료효(94.87%)대우대조조(87.18%),량조차이구유통계학의의(P<0.05);치료조적불량반응솔(5.13%)소우대조조(12.82%),량조차이구유통계학의의(P<0.05)。결론의나보리연합경록새진치료고혈압적림상료효현저차불량반응솔저,괄합원발성고혈압적치료,치득림상추엄。
Objective?To investigate the clinical efficacy of enalapril and hydrochlorothiazide in the treatment of hypertension. Methods 78 cases of hypertensive patients, randomly divided into treatment group and control group with 39 cases in each group, respectively with enalapril monotherapy and enalapril plus hydrochlorothiazide treatment. Results The efficacy of the treatment group (94.87%) than that in the control group (87.18%), the difference between the two groups was statistically significant (P<0.05);adverse reaction rates in the treatment group (5.13%) than the control group (12.82%), the difference between the two groups was statistically significant (P<0.05). Conclusion Enalapril and hydrochlorothiazide in the treatment of hypertension clinical curative effect and the low rate of adverse reactions, treatment for hypertension, is worth the clinical promotion.